Press releases

New cochlear implant technology to significantly increase hearing potential and quality of life for the severe-to-profoundly deaf.

CryoPlasty® Therapy may be an alternative to surgery or limb amputation

“We made progress on a number of fronts, most notably the integration of Guidant and our quality initiatives," said Jim Tobin, President and CEO.

FLEXView™ System enables physicians to perform less-invasive cardiac surgical ablation procedures

Company welcomes FDA statement that drug-eluting stents remain safe and effective when used for approved indications

NEJM editorial and articles describe results of two randomized clinical trials, PASSION and TYPHOON

Boston Scientific Corporation (NYSE: BSX) today announced four-year follow-up data from its TAXUS II paclitaxel-eluting stent system...

Initial six-month results show positive outcomes in diabetic patients; safety events for diabetic subset lower than overall patient population

International data suggests low revascularization rates for both TAXUS stent and PROMUS™ (XIENCE™ V) stent

PROMUS Stent joins market-leading TAXUS® Paclitaxel-Eluting Coronary Stent Systems